Market Scope

Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis

Choose Your Experience

Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis

Latest Market Reports

Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.

Latest Industry News & Trends

5/16/2025
BreakingDry EyeGlaucomaRegulation
Nearly 76 Thousand Cases of Ocular Lubricants Recalled, US FDA Alert Says
Nearly 76 Thousand Cases of Ocular Lubricants Recalled, US FDA Alert Says

The US FDA issued alerts recently regarding the recalls of five ocular lubricant products and one generic glaucoma medication. BRS Analytical Services, a contract testing laboratory based in St. Lo...

5/16/2025
BreakingDiagnosticEuropeOCTRegulation
Intalight Receives CE Marking for Dream OCT Swept Source Imaging
Intalight Receives CE Marking for Dream OCT Swept Source Imaging

Ophthalmic diagnostic company Intalight announced May 15 that it had received CE marking for its Dream optical coherence tomography (OCT) platform. Intalight, with offices in San Jose, California, ...

5/16/2025
BreakingCataractEuropeIOLRegulationSurgical
Bausch + Lomb Receives CE Marking for Preloaded LuxLife Trifocal IOL
Bausch + Lomb Receives CE Marking for Preloaded LuxLife Trifocal IOL

Bausch + Lomb announced May 7 that the LuxLife trifocal intraocular lens (IOL) had received CE marking in Europe. The company said the nondiffractive LuxLife has an uninterrupted, continuous refrac...

5/16/2025
BiosimilarsBreakingCataractDry EyeGlaucomaIOLLaserOcular CancerRetinaRevenueSurgical
Q1-2025 Ophthalmic Revenue Roundup for Alcon, Immunocore, Harrow, Sight Sciences, ANI, Iridex, and Xbrane
Q1-2025 Ophthalmic Revenue Roundup for Alcon, Immunocore, Harrow, Sight Sciences, ANI, Iridex, and Xbrane

Alcon reported May 13 that its Q1-2025 net sales were $2.45 billion, on par with $2.44 billion in Q1-2024 and up 3 percent on a constant currency basis. Surgical net sales totaled $1.33 billion (do...

5/16/2025
BreakingDealsPresbyopia
Lenz Licenses Presbyopia Drop Candidate to Lotus Pharmaceutical for Korea, Southeast Asia
Lenz Licenses Presbyopia Drop Candidate to Lotus Pharmaceutical for Korea, Southeast Asia

Lenz Therapeutics announced May 9 a license agreement with Taiwan’s Lotus Pharmaceutical for exclusive rights to market LNZ100 (1.75% aceclidine) for presbyopia in South Korea and certain countries...

5/16/2025
BreakingRegulationThyroid Eye Disease
US FDA Grants Breakthrough Status to Viridian’s Thyroid Eye Disease Candidate
US FDA Grants Breakthrough Status to Viridian’s Thyroid Eye Disease Candidate

Viridian Therapeutics announced May 7 that the US FDA had granted breakthrough therapy status to veligrotug, the company’s anti-insulin-like growth factor-1 receptor (IGF-1R) candidate for thyroid ...

5/16/2025
BreakingClinical TrialDealsIndustryRetina
Unity Bio to Cut Workforce, Seek Strategic Alternatives for UBX1325 in Retina
Unity Bio to Cut Workforce, Seek Strategic Alternatives for UBX1325 in Retina

Unity Biotechnology announced May 5 that it would reduce its workforce and seek an established ophthalmic company to continue the development of UBX1325, a Tie2/anti-VEGF bispecific antibody candid...

5/16/2025
BreakingCataractDiagnosticIndustryRefractiveRetinaSurgical
Maximilian Foerst to Lead Carl Zeiss Meditec, as Markus Weber, PhD, Steps Down
Maximilian Foerst to Lead Carl Zeiss Meditec, as Markus Weber, PhD, Steps Down

Carl Zeiss Meditec announced May 7 that Markus Weber, PhD, the company’s president and CEO, will step down of his own accord, effective May 31. Replacing Weber will be Maximilian Foerst, currently ...

Provider Surveys & Interviews

Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Table of Innovation

Choose Your Own Adventure

Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.

Safe, Secure & On Any Device

We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.

Pre-Qualified Invitations

We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.

Better Data = Better Decisions

A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.

Market Scope+ App Screen

Market Scope Methodology

A Multi-Step Approach for Accurate & Timely Data

Proprietary data

  • 20+ years of physician survey data
  • Disease models
  • Cultivated database of physicians, ASCs, and hospitals
  • Insight from our team of in-house industry experts

Public data

  • Attendance and participation at major, worldwide meetings
  • Public health systems and registries
  • Clinical study data
  • Analysis of company-published financial reports

Join Market Scope Today

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more

Register A Clinical Account

A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.

Select your country...